Drexel Morgan & Co. Baxter International Inc Transaction History

Drexel Morgan & Co.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$80.5 - $88.01 $402,258 - $439,785	-4,997 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$63.43 - $75.41 $6,977 - $8,295	110 Added 2.25%	4,997 $369,000
Q1 2018 May 10, 2018	BUY	$62.56 - $72.26 $47,545 - $54,917	760 Added 18.42%	4,887 $318,000
Q3 2017 Nov 13, 2017	BUY	$59.5 - $64.61 $10,115 - $10,983	170 Added 4.3%	4,127 $259,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,957	3,957 $240,000

970

450M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.4B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Drexel Morgan & Co., based on Form 13F filings with the SEC.

Stay updated on Drexel Morgan & Co. with notifications on news.